Endocrinología Pediátrica
13.21 €
13.9 €
Felgueroso
Whatsapp
[+34] 630 929 946
0
0,00
€
Reseña o resumen
A must have resource for clinicians and investigators interested in pulmonary embolism and deep venous thrombosis
Highly illustrated with numerous tables and graphs alongside clear concise text
Includes chapters addressing pulmonary embolism (PE) and deep venous thrombosis (DVT) in relation to diseases and disorders such as; chronic heart failure, cancer, diabetes, stroke, chronic obstructive pulmonary disease (COPD) and many more
Discusses the role the different tools offered in imaging for PE, including echocardiography, multidetector computed tomography (CT), single photon emission computed tomography (SPECT), ventilation-perfusion (V-Q) imaging, dual energy CT, and magnetic resonance angiography
Contains 29 new chapters and includes new content on epidemiology of deep venous thrombosis; use of the new anticoagulants (dabigatran, rivaroxaban, and apixaban) for DVT and PE; indications and results with thrombolytic therapy and with vena cava filters; and information and indications for invasive mechanical thrombectomy and thrombolysis
Written by an internationally recognized and respected expert in the field
Table of Contents
CHAPTER 1 Pulmonary embolism and deep venous thrombosis at autopsy
CHAPTER 2 Incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients and in emergency departments
CHAPTER 3 Case fatality rate and population mortality rate from pulmonary embolism and deep venous thrombosis
CHAPTER 4 Prognosis in acute pulmonary embolism based on right ventricular enlargement and biochemical markers in stable patients
CHAPTER 5 Prognosis in acute pulmonary embolism based on scoring systems
CHAPTER 6 Pulmonary embolism following deep venous thrombosis and outcome with untreated pulmonary embolism
CHAPTER 7 Resolution of pulmonary embolism
CHAPTER 8 Upper extremity deep venous thrombosis
CHAPTER 9 Thromboembolic disease involving the superior vena cava and brachiocephalic veins
CHAPTER 10 Venous thromboembolic disease in the four seasons
CHAPTER 11 Regional differences in the United States of rates of diagnosis of pulmonary embolism and deep venous thrombosis and mortality from pulmonary embolism
CHAPTER 12 Venous thromboembolism according to age, and in the elderly
CHAPTER 13 Pulmonary thromboembolism in infants and children
CHAPTER 14 Venous thromboembolism in men and women
CHAPTER 15 Pulmonary embolism and deep venous thrombosis in blacks and whites
CHAPTER 16 Pulmonary thromboembolism in Asians/Pacific Islanders
CHAPTER 17 Pulmonary thromboembolism in American Indians and Alaskan Natives
CHAPTER 18 Venous thromboembolism in patients with cancer
CHAPTER 19 Venous thromboembolism in patients with heart failure
CHAPTER 20 Obesity as a risk factor in venous thromboembolism
CHAPTER 21 Hypertension, smoking and cholesterol
CHAPTER 22 Overlap of venous and arterial thrombosis risk factors
CHAPTER 23 Venous thromboembolism in patients with ischemic and hemorrhagic stroke
CHAPTER 24 Paradoxical embolism
CHAPTER 25 Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease
CHAPTER 26 Pulmonary embolism and deep venous thrombosis in hospitalized patients with asthma
CHAPTER 27 Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease
CHAPTER 28 Diabetes mellitus and risk of venous thromboembolism
CHAPTER 29 Risk of venous thromboembolism with rheumatoid arthritis
CHAPTER 30 Venous thromboembolism with inflammatory bowel disease
CHAPTER 31 Venous Thromboembolism with Chronic Liver Disease
CHAPTER 32 Nephrotic syndrome
CHAPTER 33 Human immunodeficiency virus infection
CHAPTER 34 Venous thromboembolism in pregnancy
CHAPTER 35 Amniotic fluid embolism
CHAPTER 36 Air travel as a risk for pulmonary embolism and deep venous thrombosis
CHAPTER 37 Estrogen-containing oral contraceptives and venous thromboembolism
CHAPTER 38 Estrogen and Testosterone in Men
CHAPTER 39 Tamoxifen
CHAPTER 40 Venous thromboembolism following bariatric surgery
CHAPTER 41 Hypercoagulable syndrome
CHAPTER 42 Deep venous thrombosis of the lower extremities: clinical evaluation
CHAPTER 43 Clinical scoring system for assessment of deep venous thrombosis
CHAPTER 44 Clinical probability score plus single negative ultrasound for exclusion of deep venous thrombosis
CHAPTER 45 D-dimer for the exclusion of acute deep venous thrombosis
CHAPTER 46 D-dimer combined with clinical probability assessment for exclusion of acute deep venous thrombosis
CHAPTER 47 D-dimer and single negative compression ultrasound for exclusion of deep venous thrombosis
CHAPTER 48 Contrast venography
CHAPTER 49 Compression ultrasound for the diagnosis of deep venous thrombosis
CHAPTER 50 Impedance plethysmography and fibrinogen uptake tests for diagnosis of deep venous thrombosis
CHAPTER 51 Ascending CT venography and venous phase CT venography for diagnosis of deep venous thrombosis
CHAPTER 52 Magnetic resonance venography for diagnosis of deep venous thrombosis
CHAPTER 53 P-selectin and microparticles to predict deep venous thrombosis
CHAPTER 54 Clinical characteristics of patients with no prior cardiopulmonary disease
CHAPTER 55 Relation of right-sided pressures to clinical characteristics of patients with no prior cardiopulmonary disease
CHAPTER 56 The history and physical examination in all patients irrespective of prior cardiopulmonary disease
CHAPTER 57 Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes
CHAPTER 58 Clinical assessment in the critically ill
CHAPTER 59 The electrocardiogram
CHAPTER 60 The plain chest radiograph
CHAPTER 61 Arterial blood gases and the alveolar arterial oxygen difference in acute pulmonary embolism
CHAPTER 62 Fever in acute pulmonary embolism
CHAPTER 63 Leukocytosis in acute pulmonary embolism
CHAPTER 64 Alveolar dead-space in the diagnosis of pulmonary embolism
CHAPTER 65 Empirical assessment and clinical models for diagnosis of acute pulmonary embolism
CHAPTER 66 Prognostic models for pulmonary embolism
CHAPTER 67 D-dimer for the exclusion of acute pulmonary embolism
CHAPTER 68 D-dimer combined with clinical probability for exclusion of acute pulmonary embolism
CHAPTER 69 D-dimer in combination with amino-terminal pro-B-type natriuretic peptide for exclusion of acute pulmonary embolism
CHAPTER 70 Tissue plasminogen activator, plasminogen activator inhibitor-1, and thrombin-antithrombin III complexes in the exclusion of acute pulmonary embolism
CHAPTER 71 Echocardiogram in the diagnosis of acute pulmonary embolism
CHAPTER 72 Trends in the use of diagnostic imaging in patients hospitalized with acute pulmonary embolism
CHAPTER 73 Techniques of perfusion and ventilation imaging
CHAPTER 74 Ventilation perfusion lung scan criteria for interpretation prior to the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)
CHAPTER 75 Observations from PIOPED: ventilation perfusion lung scans alone and in combination with clinical assessment
CHAPTER 76 Ventilation perfusion lung scans according to complexity of lung disease
CHAPTER 77 Perfusion lung scans alone in acute pulmonary embolism
CHAPTER 78 Probability interpretation of ventilation perfusion lung scans in relation to largest pulmonary arterial branches in which pulmonary embolism is observed
CHAPTER 79 Revised criteria for evaluation of lung scans recommended by nuclear physicians in PIOPED
CHAPTER 80 Criteria for very low probability interpretation of ventilation perfusion lung scans
CHAPTER 81 Probability assessment based on the number of mismatched segmental equivalent perfusion defects
CHAPTER 82 Probability assessment based on the number of mismatched vascular defects and stratification according to prior cardiopulmonary disease
CHAPTER 83 The addition of clinical assessment to stratification according to prior cardiopulmonary disease further optimizes the interpretation of ventilation perfusion lung scans
CHAPTER 84 Pulmonary scintigraphy scans since PIOPED
CHAPTER 85 Single photon emission computed tomographic (SPECT) lung scans
CHAPTER 86 SPECT with radiolabeled markers
CHAPTER 87 Standard and augmented techniques in pulmonary angiography
CHAPTER 88 Subsegmental pulmonary embolism
CHAPTER 89 Quantification of pulmonary emboli by conventional and CT angiography
CHAPTER 90 Complications of pulmonary angiography
CHAPTER 91 Contrast-enhanced spiral CT for the diagnosis of acute pulmonary embolism before the Prospective Investigation of Pulmonary Embolism Diagnosis
CHAPTER 92 Methods of PIOPED II
CHAPTER 93 Multidetector spiral CT of the chest for acute pulmonary embolism: results of the PIOPED II trial
CHAPTER 94 Multidetector CT pulmonary angiography since PIOPED II
CHAPTER 95 Outcome studies of pulmonary embolism versus accuracy
CHAPTER 96 Contrast-induced nephropathy
CHAPTER 97 Radiation exposure and risk
CHAPTER 98 Magnetic resonance angiography for the diagnosis of acute pulmonary embolism
CHAPTER 100 Diagnosis of Pulmonary Embolism in the Coronary Care Unit
CHAPTER 101 Silent Pulmonary Embolism with Deep Venous Thrombosis
CHAPTER 102 Fat Embolism Syndrome
CHAPTER 103 Diagnostic approach to acute pulmonary embolism
CHAPTER 104 Warfarin and other vitamin K antagonists
CHAPTER 105 Unfractionated heparin, low-molecular-weight heparin, heparinoid and pentasaccharide
CHAPTER 106 Parenteral inhibitors of factors Va, VIIIa, tissue factor and thrombin
CHAPTER 107 Novel oral anticoagulants
CHAPTER 108 Aspirin for venous thromboembolism
CHAPTER 109 Immediate therapeutic levels of heparin in relation to timing of recurrent events
CHAPTER 110 Intermittent pneumatic compression
CHAPTER 111 Graduated compression stockings
CHAPTER 112 Ankle exercise and venous blood velocity
CHAPTER 113 Thrombolytic therapy for deep venous thrombosis
CHAPTER 114 Mechanical and ultrasonic enhancement of catheter-directed thrombolytic therapy for deep venous thrombosis
CHAPTER 115 Thrombolytic therapy for treatment of acute pulmonary embolism
CHAPTER 116 Catheter-tip embolectomy in the management of acute massive pulmonary embolism
CHAPTER 117 Vena cava filters
CHAPTER 118 Withholding treatment of patients with acute pulmonary embolism who have a high risk of bleeding provided and negative serial noninvasive leg tests
CHAPTER 119 Home treatment of deep venous thrombosis
CHAPTER 120 Home treatment of acute pulmonary embolism
CHAPTER 121 Pulmonary embolectomy
CHAPTER 122 Chronic thromboembolic pulmonary hypertension and pulmonary thromboendarterectomy
CHAPTER 123 Prevention and treatment of deep venous thrombosis and acute pulmonary embolism: American College of Chest Physicians Guidelines
Highly illustrated with numerous tables and graphs alongside clear concise text
Includes chapters addressing pulmonary embolism (PE) and deep venous thrombosis (DVT) in relation to diseases and disorders such as; chronic heart failure, cancer, diabetes, stroke, chronic obstructive pulmonary disease (COPD) and many more
Discusses the role the different tools offered in imaging for PE, including echocardiography, multidetector computed tomography (CT), single photon emission computed tomography (SPECT), ventilation-perfusion (V-Q) imaging, dual energy CT, and magnetic resonance angiography
Contains 29 new chapters and includes new content on epidemiology of deep venous thrombosis; use of the new anticoagulants (dabigatran, rivaroxaban, and apixaban) for DVT and PE; indications and results with thrombolytic therapy and with vena cava filters; and information and indications for invasive mechanical thrombectomy and thrombolysis
Written by an internationally recognized and respected expert in the field
Table of Contents
CHAPTER 1 Pulmonary embolism and deep venous thrombosis at autopsy
CHAPTER 2 Incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients and in emergency departments
CHAPTER 3 Case fatality rate and population mortality rate from pulmonary embolism and deep venous thrombosis
CHAPTER 4 Prognosis in acute pulmonary embolism based on right ventricular enlargement and biochemical markers in stable patients
CHAPTER 5 Prognosis in acute pulmonary embolism based on scoring systems
CHAPTER 6 Pulmonary embolism following deep venous thrombosis and outcome with untreated pulmonary embolism
CHAPTER 7 Resolution of pulmonary embolism
CHAPTER 8 Upper extremity deep venous thrombosis
CHAPTER 9 Thromboembolic disease involving the superior vena cava and brachiocephalic veins
CHAPTER 10 Venous thromboembolic disease in the four seasons
CHAPTER 11 Regional differences in the United States of rates of diagnosis of pulmonary embolism and deep venous thrombosis and mortality from pulmonary embolism
CHAPTER 12 Venous thromboembolism according to age, and in the elderly
CHAPTER 13 Pulmonary thromboembolism in infants and children
CHAPTER 14 Venous thromboembolism in men and women
CHAPTER 15 Pulmonary embolism and deep venous thrombosis in blacks and whites
CHAPTER 16 Pulmonary thromboembolism in Asians/Pacific Islanders
CHAPTER 17 Pulmonary thromboembolism in American Indians and Alaskan Natives
CHAPTER 18 Venous thromboembolism in patients with cancer
CHAPTER 19 Venous thromboembolism in patients with heart failure
CHAPTER 20 Obesity as a risk factor in venous thromboembolism
CHAPTER 21 Hypertension, smoking and cholesterol
CHAPTER 22 Overlap of venous and arterial thrombosis risk factors
CHAPTER 23 Venous thromboembolism in patients with ischemic and hemorrhagic stroke
CHAPTER 24 Paradoxical embolism
CHAPTER 25 Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease
CHAPTER 26 Pulmonary embolism and deep venous thrombosis in hospitalized patients with asthma
CHAPTER 27 Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease
CHAPTER 28 Diabetes mellitus and risk of venous thromboembolism
CHAPTER 29 Risk of venous thromboembolism with rheumatoid arthritis
CHAPTER 30 Venous thromboembolism with inflammatory bowel disease
CHAPTER 31 Venous Thromboembolism with Chronic Liver Disease
CHAPTER 32 Nephrotic syndrome
CHAPTER 33 Human immunodeficiency virus infection
CHAPTER 34 Venous thromboembolism in pregnancy
CHAPTER 35 Amniotic fluid embolism
CHAPTER 36 Air travel as a risk for pulmonary embolism and deep venous thrombosis
CHAPTER 37 Estrogen-containing oral contraceptives and venous thromboembolism
CHAPTER 38 Estrogen and Testosterone in Men
CHAPTER 39 Tamoxifen
CHAPTER 40 Venous thromboembolism following bariatric surgery
CHAPTER 41 Hypercoagulable syndrome
CHAPTER 42 Deep venous thrombosis of the lower extremities: clinical evaluation
CHAPTER 43 Clinical scoring system for assessment of deep venous thrombosis
CHAPTER 44 Clinical probability score plus single negative ultrasound for exclusion of deep venous thrombosis
CHAPTER 45 D-dimer for the exclusion of acute deep venous thrombosis
CHAPTER 46 D-dimer combined with clinical probability assessment for exclusion of acute deep venous thrombosis
CHAPTER 47 D-dimer and single negative compression ultrasound for exclusion of deep venous thrombosis
CHAPTER 48 Contrast venography
CHAPTER 49 Compression ultrasound for the diagnosis of deep venous thrombosis
CHAPTER 50 Impedance plethysmography and fibrinogen uptake tests for diagnosis of deep venous thrombosis
CHAPTER 51 Ascending CT venography and venous phase CT venography for diagnosis of deep venous thrombosis
CHAPTER 52 Magnetic resonance venography for diagnosis of deep venous thrombosis
CHAPTER 53 P-selectin and microparticles to predict deep venous thrombosis
CHAPTER 54 Clinical characteristics of patients with no prior cardiopulmonary disease
CHAPTER 55 Relation of right-sided pressures to clinical characteristics of patients with no prior cardiopulmonary disease
CHAPTER 56 The history and physical examination in all patients irrespective of prior cardiopulmonary disease
CHAPTER 57 Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes
CHAPTER 58 Clinical assessment in the critically ill
CHAPTER 59 The electrocardiogram
CHAPTER 60 The plain chest radiograph
CHAPTER 61 Arterial blood gases and the alveolar arterial oxygen difference in acute pulmonary embolism
CHAPTER 62 Fever in acute pulmonary embolism
CHAPTER 63 Leukocytosis in acute pulmonary embolism
CHAPTER 64 Alveolar dead-space in the diagnosis of pulmonary embolism
CHAPTER 65 Empirical assessment and clinical models for diagnosis of acute pulmonary embolism
CHAPTER 66 Prognostic models for pulmonary embolism
CHAPTER 67 D-dimer for the exclusion of acute pulmonary embolism
CHAPTER 68 D-dimer combined with clinical probability for exclusion of acute pulmonary embolism
CHAPTER 69 D-dimer in combination with amino-terminal pro-B-type natriuretic peptide for exclusion of acute pulmonary embolism
CHAPTER 70 Tissue plasminogen activator, plasminogen activator inhibitor-1, and thrombin-antithrombin III complexes in the exclusion of acute pulmonary embolism
CHAPTER 71 Echocardiogram in the diagnosis of acute pulmonary embolism
CHAPTER 72 Trends in the use of diagnostic imaging in patients hospitalized with acute pulmonary embolism
CHAPTER 73 Techniques of perfusion and ventilation imaging
CHAPTER 74 Ventilation perfusion lung scan criteria for interpretation prior to the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)
CHAPTER 75 Observations from PIOPED: ventilation perfusion lung scans alone and in combination with clinical assessment
CHAPTER 76 Ventilation perfusion lung scans according to complexity of lung disease
CHAPTER 77 Perfusion lung scans alone in acute pulmonary embolism
CHAPTER 78 Probability interpretation of ventilation perfusion lung scans in relation to largest pulmonary arterial branches in which pulmonary embolism is observed
CHAPTER 79 Revised criteria for evaluation of lung scans recommended by nuclear physicians in PIOPED
CHAPTER 80 Criteria for very low probability interpretation of ventilation perfusion lung scans
CHAPTER 81 Probability assessment based on the number of mismatched segmental equivalent perfusion defects
CHAPTER 82 Probability assessment based on the number of mismatched vascular defects and stratification according to prior cardiopulmonary disease
CHAPTER 83 The addition of clinical assessment to stratification according to prior cardiopulmonary disease further optimizes the interpretation of ventilation perfusion lung scans
CHAPTER 84 Pulmonary scintigraphy scans since PIOPED
CHAPTER 85 Single photon emission computed tomographic (SPECT) lung scans
CHAPTER 86 SPECT with radiolabeled markers
CHAPTER 87 Standard and augmented techniques in pulmonary angiography
CHAPTER 88 Subsegmental pulmonary embolism
CHAPTER 89 Quantification of pulmonary emboli by conventional and CT angiography
CHAPTER 90 Complications of pulmonary angiography
CHAPTER 91 Contrast-enhanced spiral CT for the diagnosis of acute pulmonary embolism before the Prospective Investigation of Pulmonary Embolism Diagnosis
CHAPTER 92 Methods of PIOPED II
CHAPTER 93 Multidetector spiral CT of the chest for acute pulmonary embolism: results of the PIOPED II trial
CHAPTER 94 Multidetector CT pulmonary angiography since PIOPED II
CHAPTER 95 Outcome studies of pulmonary embolism versus accuracy
CHAPTER 96 Contrast-induced nephropathy
CHAPTER 97 Radiation exposure and risk
CHAPTER 98 Magnetic resonance angiography for the diagnosis of acute pulmonary embolism
CHAPTER 100 Diagnosis of Pulmonary Embolism in the Coronary Care Unit
CHAPTER 101 Silent Pulmonary Embolism with Deep Venous Thrombosis
CHAPTER 102 Fat Embolism Syndrome
CHAPTER 103 Diagnostic approach to acute pulmonary embolism
CHAPTER 104 Warfarin and other vitamin K antagonists
CHAPTER 105 Unfractionated heparin, low-molecular-weight heparin, heparinoid and pentasaccharide
CHAPTER 106 Parenteral inhibitors of factors Va, VIIIa, tissue factor and thrombin
CHAPTER 107 Novel oral anticoagulants
CHAPTER 108 Aspirin for venous thromboembolism
CHAPTER 109 Immediate therapeutic levels of heparin in relation to timing of recurrent events
CHAPTER 110 Intermittent pneumatic compression
CHAPTER 111 Graduated compression stockings
CHAPTER 112 Ankle exercise and venous blood velocity
CHAPTER 113 Thrombolytic therapy for deep venous thrombosis
CHAPTER 114 Mechanical and ultrasonic enhancement of catheter-directed thrombolytic therapy for deep venous thrombosis
CHAPTER 115 Thrombolytic therapy for treatment of acute pulmonary embolism
CHAPTER 116 Catheter-tip embolectomy in the management of acute massive pulmonary embolism
CHAPTER 117 Vena cava filters
CHAPTER 118 Withholding treatment of patients with acute pulmonary embolism who have a high risk of bleeding provided and negative serial noninvasive leg tests
CHAPTER 119 Home treatment of deep venous thrombosis
CHAPTER 120 Home treatment of acute pulmonary embolism
CHAPTER 121 Pulmonary embolectomy
CHAPTER 122 Chronic thromboembolic pulmonary hypertension and pulmonary thromboendarterectomy
CHAPTER 123 Prevention and treatment of deep venous thrombosis and acute pulmonary embolism: American College of Chest Physicians Guidelines
Ficha del libro
Autores
Materias
ISBN
978-1-119-03908-2
EAN
9781119039082
Editor
John Wiley & Sons, Ltd.
Stock
NO
Idioma
Inglés
Nivel
Profesional
Formato
Encuadernado
Tapa Dura
Páginas
704
Largo
-
Ancho
-
Peso
-
Edición
Fecha de edición
07-07-2016
Año de edición
2016
Nº de ediciones
3
Colección
-
Nº de colección
-
